Cato Capital LLC v. Hemispherx Biopharma Inc.

OPINION *

GREENAWAY, JR., Circuit Judge.

Plaintiff-Appellant Cato Capital, 'LLC (“Cato”) appeals from the final judgment entered by the District Court in favor of Defendant-Appellee Hemispherx Biophar-ma, Inc. (“Hemispherx”) on Cato’s breach of contract claim. Cato, an investment bank, sued Hemispherx, a biopharmaceutical company and former client, to recover a placement fee after several companies invested millions of dollars in Hemis-pherx — notwithstanding the fact that: (1) Cato did not facilitate these investments, and (2) these transactions closed after Cato’s engagement with Hemispherx…